MRMD - MariMed Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
3.7101
-0.2499 (-6.31%)
As of 3:33PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close3.9600
Open4.0400
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range3.7100 - 4.0500
52 Week Range0.4550 - 5.8000
Volume269,126
Avg. Volume726,722
Market Cap788.229M
Beta (3Y Monthly)3.36
PE Ratio (TTM)N/A
EPS (TTM)-0.1080
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE9 hours ago

    MariMed Is Expanding Cannabis and CBD Hemp Operations, New Capital Infusion

    NEW YORK, NY / ACCESSWIRE / December 10, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...

  • Better Marijuana Stock: MariMed vs. MedMen
    Motley Fool8 days ago

    Better Marijuana Stock: MariMed vs. MedMen

    Which of these two U.S. marijuana stocks is poised to be the bigger winner?

  • Benzinga11 days ago

    Medical Marijuana Is Making Big Money In Maryland

    When medical cannabis became legal in Maryland last year, New Frontier Data projected 2018 sales would come in at around $46 million. When compared to other states with high median incomes, such as Hawaii, California and Massachusetts, Maryland remains a fairly inexpensive state in which to live. Marijuana is still only medically legal in Maryland, and it’s already on pace to bring in $1 million in its first year.

  • GlobeNewswire13 days ago

    Navy Capital Makes $14+ Million Investment in MariMed

    Navy Capital is the first US-based Long/Short Equity Hedge Fund dedicated solely to the legal cannabis industry. “Navy Capital's $14.7 million investment in MariMed reflects our belief that MariMed is one of the best-managed multi-state cannabis operators in the United States,” said Sean Stiefel, Navy Capital portfolio manager.

  • PR Newswire14 days ago

    Cannabis Sector Leaders Leveraging Expertise and Real Estate as Possible Federal Legalization Looms

    The pendulum of cannabis legalization in the US seems to have begun to swing back towards a positive stance over the first half of 2018. With the rise of cannabis legalization across North America, has come with it a rise in the prevalence of niche expertise in the sector.

  • Benzinga14 days ago

    As Congress Bickers Over Farm Bill, MariMed Gets Internationally Busy Down Under

    As the industry impatiently awaits passage of the 2018 Farm Bill and pending removal of hemp from the Controlled Substances Act, companies are quickly moving to position themselves as leading suppliers of hemp-based CBD products, and investors are all too happy to help foot the bill. Two companies that have been particularly aggressive in their pursuit of the hemp-based CBD market have been Elixinol Global Ltd. (OTCQX: ELLXF) and MariMed, Inc. (OTCQB:MRMD). Shares for the IPO were sold at $1.00 AUD per share ($0.73 USD), but the stock quickly climbed to $1.82 AUD ($1.32 USD) within the first week of trading.

  • GlobeNewswire14 days ago

    East Coast, the New Cannabis Frontier? CLS Holdings USA, Inc. (OTCQB: CLSH), Acreage Holdings, MariMed Inc.

    POINT ROBERTS, Wash. and LAS VEGAS, Nov. 26, 2018 (GLOBE NEWSWIRE) -- www.Investorideas.com, a global news source covering marijuana and hemp stocks, issues a sector snapshot looking at multi-geographically located cannabis companies positioning to benefit from the recent headline news Massachusetts makes history with launch of U.S. East Coast's first legal pot shops. With this recent milestone, investors are looking East for new doors opening in the cannabis market, once dominated by the West Coast. How big is the opportunity for the players competing for market share?  According to an article in GreenMarketReport, “Massachusetts began selling adult use cannabis this week.

  • GlobeNewswire20 days ago

    MariMed Reports Third Quarter 2018 Financial Results

    NORWOOD, MA, Nov. 20, 2018 (GLOBE NEWSWIRE) --  MariMed Inc. (MRMD), a multi-state cannabis operator, reported third quarter 2018 financial results for the quarter and nine months ended September 30, 2018. The Company continued to grow quarterly year-over-year revenue since the second quarter of 2016. Operating income increased 75% to approximately $2.0 from approximately $1.1 million during the nine months ended September 30, 2017.

  • Benzinga26 days ago

    The 10 Most Actively Traded OTCQX And OTCQB Stocks In October

    When the market is volatile, investors flee to safety. Often, investors will retreat out of growth names and into more established industries. We saw that trend play out in October on the over-the-counter ...

  • Better Marijuana Stock: MariMed Inc. vs. The Green Organic Dutchman Holdings Ltd.
    Motley Fool26 days ago

    Better Marijuana Stock: MariMed Inc. vs. The Green Organic Dutchman Holdings Ltd.

    If you could only buy one of these marijuana stocks, here's the better choice.

  • The Big Election Win for Marijuana Hardly Anyone Is Talking About
    Motley Fool27 days ago

    The Big Election Win for Marijuana Hardly Anyone Is Talking About

    This state didn't vote to legalize recreational marijuana, but it did the next best thing.

  • Benzinga28 days ago

    MariMed, GenCanna Global Form Hemp Partnership

    A new company is set to join the growing hemp market. MariMed Inc  (OTC: MRMD ) has agreed to invest $30 million in GenCanna Global as part of a strategic partnership.  What Happened MariMed develops and ...

  • GlobeNewswire28 days ago

    MariMed Enters Fast-Growing Hemp CBD World Market in Partnership with GenCanna Global

    WINCHESTER, KY and NEWTON, MA, Nov. 12, 2018 (GLOBE NEWSWIRE) --  MariMed Inc. (MRMD) and GenCanna Global Inc. (“GenCanna”) jointly announced today that the companies have entered into an agreement whereby MariMed has invested $30 million in GenCanna, and the companies have created a strategic partnership, including a long-term supply agreement. The partnership expands MariMed’s robust product development capabilities and strengthens GenCanna’s position as a global leader in the Hemp CBD industry.

  • The 7 Best Stocks to Buy Now That Jeff Sessions Is Gone
    InvestorPlacelast month

    The 7 Best Stocks to Buy Now That Jeff Sessions Is Gone

    When the dust settled from the midterm elections, President Donald Trump did something both shocking and inevitable: he fired Attorney General Jeff Sessions. Occupying a contentious tenure from the start, Sessions passive-aggressively clashed with Trump by recusing himself from the Russian-meddling inquiry. Political insiders characterized Sessions as having a “tough sheriff” personality.

  • ACCESSWIRElast month

    Marijuana Stocks Moving Higher On Breaking News

    CORAL GABLES, FL / ACCESSWIRE / November 7,2018 / Medical cannabis and recreational marijuana have been put in a very bright spotlight on Wednesday. Missouri and Utah approved medical marijuana initiatives, joining 31 other states that already allow prescription sales. ICC International Cannabis Corp. (KNHBF) (WRLD) a has held its trading level around $0.50 for the last week and on the heels of major marijuana market developments, the company announced today that it has received an inaugural purchase order for 10,000mL of Tetrahydrocannabinol Cannabis oil, 5,000g of dried Cannabis flower and 5,000mL of Cannabidiol oil.

  • GlobeNewswirelast month

    MariMed Hires Cannabis Analyst Charles Finnie as Chief Strategy Officer

    Finnie to lead MariMed M&A, strategic investment, corporate strategy, investor relations Finnie sees biggest opportunity in undervalued US cannabis companies NORWOOD,.

  • ACCESSWIRElast month

    CBD Stocks on The Rebound

    HENDERSON, NV / ACCESSWIRE / November 6, 2018 / As the stock market plummeted early October cannabis companies stayed strong, buoyed up by legislative changes in Canada. The cannabis market appears set ...

  • The 5 Top-Performing Marijuana Stocks Since the Beginning of 2016
    Motley Foollast month

    The 5 Top-Performing Marijuana Stocks Since the Beginning of 2016

    The best pot stock is up more than 6,700% in less than three years.

  • Investopedialast month

    Marijuana and Midterms: What You Need to Know

    The legalization of medical marijuana and recreational marijuana have emerged as key talking points in the run up to the election. Seven states have already legalized recreational marijuana, while roughly 30 other states have passed medical cannabis in some form. On Tuesday, four more states could be added to those lists. Legalization of the drug for recreational use is on the ballot in North Dakota and Michigan, while voters in Missouri and Utah will decide whether to legalize cannabis for medical purposes.

  • Why This Marijuana Stock Jumped 19% in October While the Group Got Clobbered
    Motley Foollast month

    Why This Marijuana Stock Jumped 19% in October While the Group Got Clobbered

    U.S.-based MariMed bucked the downtrend in the cannabis sector last month. Here's what investors should know.

  • GlobeNewswirelast month

    MariMed Co-Sponsoring  Maryland Medical Cannabis Forum Nov. 8 in Baltimore

    In-depth discussion of Medical Marijuana Research and PracticeFeatured speakers Dr. Jokūbas Žiburkus (Canntelligence), Dr. Dustin Sulak (Healer.com),Panel hosted by CNBC’s.

  • The 3 Best Marijuana Stocks in October
    Motley Foollast month

    The 3 Best Marijuana Stocks in October

    Or, should I say, the only three pot stocks to finish in the green last month.

  • 7 U.S. Marijuana Stocks to Buy for the Midterm Elections
    InvestorPlacelast month

    7 U.S. Marijuana Stocks to Buy for the Midterm Elections

    Naturally, this has significant implications for marijuana stocks. Favorable legislation stateside and in Canada boosted marijuana stocks like Tilray (NASDAQ:TLRY) into the stratosphere. While the pain is extremely pronounced for pot stocks, I believe the political environment presents high-risk/high-reward contrarian opportunities.

  • Why MariMed Inc. Stock Is on the Rise Today
    Motley Foollast month

    Why MariMed Inc. Stock Is on the Rise Today

    The company acquires a consultancy for the cannabis industry ahead of New Jersey's vote to potentially legalize recreational pot.

  • GlobeNewswirelast month

    MariMed Acquires NJ-Based BSC Group Cannabis Firm; Strengthens Operations, Branding Teams

    MariMed Inc., a multi-state cannabis organization that develops, owns and manages cannabis facilities and branded products lines, announced today that it has finalized the acquisition of BSC Group, a highly respected cannabis firm headquartered in New Jersey that over the last three years has been engaged in competitive licensing, consulting and operations management across the country. BSC founders and managing partners, Brian Staffa and Amber Staffa, will join the MariMed leadership team, bringing under the MariMed umbrella their extensive cannabis expertise, resources, intellectual property and a vast network of highly specialized affiliates spanning regulated fields of commercial cannabis, food and beverage, commercial agriculture, pharmaceuticals, regulatory compliance, consumer psychology, and the applied sciences.